Tag: IHL

Impression Healthcare ASX IHL files patent non-intrusive treatment obstructive sleep apnoea pill

Impression Healthcare files patent for non-intrusive treatment of obstructive sleep apnoea

Medical cannabis company Impression Healthcare (ASX: IHL) is continuing on its path to developing an effective solution for obstructive sleep apnoea (OSA) having filed a...
Impression Healthcare ASX IHL John Michailidis Incannex cannabinoid pharmaceutical

Impression Healthcare recruits Big Pharma executive to complete cannabinoid drug discovery goal

Medical cannabis company Impression Healthcare (ASX: IHL) has continued its top-tier recruitment drive with the addition of yet another pharmaceutical industry expert into its...
Impression Healthcare ASX IHL cannabidiol head trauma

Impression Healthcare files patent application for medicinal CBD drug to alleviate concussion injuries

Impression Healthcare (ASX: IHL) has opted to file a patent application for a neuroprotective agent that could potentially aid people that suffer concussions – a...
Impression Healthcare ASX IHL medical advisory board wholesale order Incannex CBD oils

Duo of renowned specialists join Impression Healthcare, Incannex CBD oils on route

Following a busy few months on the recruitment and brand licencing fronts, Impression Healthcare (ASX: IHL) has appointed an additional duo of leading medical...
Impression Healthcare ASX IHL medical advisory board Rondhir Jithoo Simon Hinckfuss

Impression Healthcare appoints two globally renowned medical experts for cannabis medicines projects

Impression Healthcare (ASX: IHL) has bolstered its Medical Advisory Board by appointing two leading medical experts possessing extensive expertise within two key market niches currently being...

Impression Healthcare commences obstructive sleep apnoea clinical trial

Following last week’s deal that saw Impression Healthcare (ASX: IHL) secure the cannabinoid materials it needs to conduct a series of clinical trials, the...
Impression Healthcare ASX IHL Incannex Pharmaceuticals medicinal cannabis oil supply cannabinoid

Impression Healthcare secures long term oil supply agreement, unveils new cannabis discovery brand Incannex

Impression Healthcare (ASX: IHL) has moved to extend its medicinal cannabis market coverage after unveiling the all-new cannabinoid drug discovery brand Incannex Pharmaceuticals. As a...
ONE Championship Impression Healthcare ASX IHL mouthguard concussion research CBD

Impression Healthcare becomes official supplier and research partner to ONE Championship

Barely a week after Aurora announced a deal with the Ultimate Fighting Championship (UFC), Australia’s very own Impression Healthcare (ASX: IHL) has made a...
Dr Sud Agarwal Impression Healthcare ASX IHL Cannvalate cannabis

Impression Healthcare appoints leading medicinal cannabis pioneer Dr Sud Agarwal to its board

Impression Healthcare (ASX: IHL) has tweaked its internal structure by appointing Dr Sud Agarwal, a leading figure in the medicinal cannabis industry as its...
Impression Healthcare ASX IHL FiTGuard concussion monitoring system licence new countries

Impression Healthcare extends exclusive deal with FiTGuard for concussion monitoring

Impression Healthcare (ASX: IHL) has extended the global coverage of its Fitguard by Gameday concussion monitoring system by extending its exclusive licencing agreement with...
Impression Healthcare ASX IHL Dronabinol product supply agreement sleep apnoea trials sales

Impression Healthcare hones in on sleep apnoea trial with proprietary Dronabinol formulation

Impression Healthcare (ASX: IHL) is on the brink of conducting a sleep apnoea trial with its own variant of the cannabinoid medicine Dronabinol after...
Impression Healthcare ASX IHL Boxing Australia brain injury mouthguard CBD cannabidiol

Impression Healthcare becomes Boxing Australia’s official supplier and concussion research partner

Impression Healthcare (ASX: IHL) has unveiled a brand-new exclusive research and supply agreement that will see the healthcare company become the official traumatic brain...
Impression Healthcare ASX IHL AXIM gingivitis periodontitis gum disease cannabidiol CBD cannabis mouthwash toothpaste

Impression Healthcare registers clinical trial for CBD-based mouthwash and toothpaste

Impression Healthcare’s (ASX: IHL) “world first” clinical trial using its cannabidiol (CBD)-based mouthwash and toothpaste to treat gingivitis and periodontitis (gum disease) has now...
Impression Healthcare ASX IHL FiTGuard smart mouthguard concussion monitoring

Impression Healthcare to supply concussion monitoring FitGuard mouthguard system

Impression Healthcare (ASX: IHL) has inked an exclusive agreement to supply the concussion monitoring FitGuard mouthguard system. Under the agreement with Force Impact Technologies, Impression...
Impression Healthcare ASX IHL AXIM cannabis CBD periodontitis toothpaste mouthwash clinical trial

Impression Healthcare signs first binding agreement with AXIM Biotechnologies, clinical trial imminent

Impression Healthcare (ASX: IHL) is set to deliver a toothpaste and mouthwash product that adds yet another option for consumers searching for cannabidiol-based products. Earlier...
Impression Healthcare Cannvalate ASX IHL medical cannabis trials

Impression Healthcare aims for competitive edge over ‘cure-all’ suppliers with unique medical cannabis trials

Impression Healthcare (ASX: IHL) is on the road to gaining a competitive edge in the medicinal cannabis field with four upcoming trials aimed at...
Impression Healthcare ASX IHL Cannvalate medical cannabis trial distribution deal traumatic brain injury CBD oil

Impression Healthcare teams up with Cannvalate in ‘first of its kind’ medical cannabis trial and distribution...

Disruptive healthcare company Impression Healthcare (ASX: IHL) has teamed up with Australia’s largest network of medical cannabis clinics, Cannvalate, to distribute cannabinoid (CBD) medicines...
Impression Healthcare ASX IHL cannabis medicine dronabinol treatment sleep apnoea

Impression Healthcare signs deal to progress cannabis medicine ‘dronabinol’ towards treatment of sleep apnoea

Impression Healthcare’s (ASX: IHL) dronabinol project has taken on anther dimension after the company signed a memorandum of understanding and exclusivity agreement with RespireRx...
Impression Healthcare 1300SMILES ASX IHL ONT supply agreement dentist mouthguard

Impression Healthcare scores exclusive supply agreement with corporate dentist 1300SMILES

Impression Healthcare (ASX: IHL) has recently made a lot of moves in the medicinal cannabis space, including receiving its cannabis distribution licenses last week. This...
Impression Healthcare medical cannabis CBD licences special access scheme Authorised Prescribers THC

Impression Healthcare secures licences to facilitate medical cannabis activities

One of Australia’s newest entrants to the medical cannabis industry, Impression Healthcare (ASX: IHL), has reached what it says is an important milestone in...
Impression Healthcare strikes cornerstone deal for next generation of FiTGuard mouthguards

Impression Healthcare strikes cornerstone deal for next generation of FiTGuard mouthguards

Dental impression company Impression Healthcare (ASX: IHL) has kicked off 2019 with a deal with Force Impact Technologies, a US-based life science company. The deal intends...

RECENT POSTS

STOCK SUMMARY

HOT TOPICS

TRENDING POSTS